BRCA1 and cancer: Additionally, DLC1 further inhibited the DYRK1A–EGFR axis, leading to DNA damage characterized by elevated levels of the double-strand break marker γH2AX and reduced regulation of DNA repair proteins p-BRCA1 and RAD51, ultimately resulting in the senescence of cancer cells [214].